Who we are

Viriom Inc. is advancing a pipeline of effective and affordable treatments for diseases of global interest. With our network of partners, we are building a global drug development platform targeting infectious and malignant diseases. Among infectious diseases, we focus on blood-borne and respiratory viral diseases. Among malignant diseases, we focus on solid tumors.

Effective and innovative treatments should be accessible to all. Our mission encompasses the goal of broadening access to new therapies for developed and developing countries.